BeOne Medicines Ltd ADR (NASDAQ:ONC) currently has a daily average trading volume of 445.03K but it saw 230402 shares traded in last market. With a market cap of 27.70B USD, the company’s current market price of $252.78 came falling about -0.52 while comparing to the previous closing price of $254.09. In past 52 weeks, the stock remained buoying in the range of price level as high as $287.88 and as low as $141.31.
The company’s shares got several price updates from the analyst firms in past one month and most recent of them is from the RBC Capital Mkts which initiated the stock as “Outperform” in its note to investors issued on April 07, 2025, recommending a price target of $312 for it. BofA Securities upgraded its recommendation for the stock as a “Buy” from “Neutral” on March 03, 2025 while assigning a price target range of $207-$320. Morgan Stanley issued its recommendations for the stock as it resumed the price target for the stock is $300.
Over the week, ONC’s stock price is moving -3.67% down while it is 8.32% when we observe its performance for the past one month. Year-to-date it is 36.85% up and over the past year, the stock is showing an upside performance of 55.48%.
Currently, BeOne Medicines Ltd ADR’s total number of outstanding shares is 109.60M. Company’s return on investment (ROI) stands at -10.56% and return on equity (ROE) at -11.44%. It has a 45.54 of forward P/E ratio. Stock’s beta reads 0.30. Stock has a price to book (P/B) ratio of 7.80 while price to sale or P/S ratio amounts to 6.63. Its return on asset (ROA) is -6.82% on average.
